INFORMAZIONI SU QUESTO EPISODIO
This week, we look at HallPass, the new candy brand betting it can deliver the full indulgence experience with just 70 calories and 1g of sugar. Then we dig into the far murkier side of longevity: Chara Health, where experimental stem-cell treatments can cost nearly $20,000 despite major questions around evidence and regulation.
Finally, we look at the $101 million XPRIZE Healthspan competition, where teams are being challenged to prove they can make older adults function meaningfully younger — using approaches ranging from gene therapy to mitochondrial rejuvenation.
Three stories, one big question: can we engineer better health — and actually prove it works?
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di This Week in Longevity.
ALTRI EPISODI IN QUESTO PODCAST
We examine why RFK Jr.'s push for peptides has sparked one of longevity medicine's biggest debates, why Halle Berry is betting on menopause care, and how a new AI-powered wearable aims to estimate hormone levels without blood tests. Are these genuine breakthroughs—or is consumer demand moving faste…
Can we delay menopause? Could a simple blood test predict Alzheimer's years before symptoms appear? And can AI learn to read your brain? This week, we unpack three of the biggest breakthroughs in longevity and preventive medicine: a potential new way to slow ovarian aging, a groundbreaking Alzheime…
Could Bryan Johnson's latest venture transform women's health? Can the bacteria living in your gut influence how fast you age? And could AI soon help diagnose depression from a simple brain scan? This week, we unpack Bryan Johnson's bold expansion into women's health through Immortals, a new study …
Why are investors suddenly pouring billions into longevity? This week, we unpack Retro Biosciences' $1.8 billion mission to add 10 healthy years to human life, the blood test claiming to reveal your body's "real" biological age, and how Google's AI drug company is trying to reinvent how m…
Apple's latest AI announcements suggest the company's biggest healthcare push yet—but is it on its way to becoming your first stop for medical advice?
Next, we explain why the FDA is tightening the rules around compounded Ozempic, what it means for patients, and how the GLP-1 revolution is continui…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Studio Talbot, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
